Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business Update

TD Cowen Upgrades Spero Therapeutics (SPRO) to Buy

August 6, 2024 7:22 AM EDT

TD Cowen analyst Ritu Baral upgraded Spero Therapeutics (NASDAQ: SPRO) from Hold to Buy.

The analyst comments "2Q24: We are upgrading SPRO to Buy on new clarity on catalyst timing and optimism for '720 Ph2a data in the 2nd half of... More